251 related articles for article (PubMed ID: 20194689)
1. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
[TBL] [Abstract][Full Text] [Related]
2. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
[TBL] [Abstract][Full Text] [Related]
3. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
[TBL] [Abstract][Full Text] [Related]
4. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
6. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
[TBL] [Abstract][Full Text] [Related]
7. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
8. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C
Malar J; 2009 Jan; 8():10. PubMed ID: 19138388
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
Mayxay M; Barends M; Brockman A; Jaidee A; Nair S; Sudimack D; Pongvongsa T; Phompida S; Phetsouvanh R; Anderson T; White NJ; Newton PN
Am J Trop Med Hyg; 2007 Feb; 76(2):245-50. PubMed ID: 17297031
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
Basco LK; Le Bras J
Ann Trop Med Parasitol; 1994 Apr; 88(2):137-44. PubMed ID: 8067809
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand.
Wongsrichanalai C; Wimonwattrawatee T; Sookto P; Laoboonchai A; Heppner DG; Kyle DE; Wernsdorfer WH
Bull World Health Organ; 1999; 77(5):392-8. PubMed ID: 10361756
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin resistance in Plasmodium falciparum malaria.
Dondorp AM; Nosten F; Yi P; Das D; Phyo AP; Tarning J; Lwin KM; Ariey F; Hanpithakpong W; Lee SJ; Ringwald P; Silamut K; Imwong M; Chotivanich K; Lim P; Herdman T; An SS; Yeung S; Singhasivanon P; Day NP; Lindegardh N; Socheat D; White NJ
N Engl J Med; 2009 Jul; 361(5):455-67. PubMed ID: 19641202
[TBL] [Abstract][Full Text] [Related]
15. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
[TBL] [Abstract][Full Text] [Related]
16. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
18. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
[TBL] [Abstract][Full Text] [Related]
19. Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
Roesch C; Mairet-Khedim M; Kim S; Lek D; Popovici J; Witkowski B
J Antimicrob Chemother; 2020 Jul; 75(7):1766-1771. PubMed ID: 32211790
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
